Abstract:To confirm that the β-phenyl-α,β-unsaturated thiocarbonyl (PUSTC) scaffold, similar to the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, acts as a core inhibitory structure for tyrosinase, twelve (Z)-5-(substituted benzylidene)-4-thioxothiazolidin-2-one ((Z)-BTTZ) derivatives were designed and synthesized. Seven of the twelve derivatives showed stronger inhibitory activity than kojic acid against mushroom tyrosinase. Compound 2b (IC50 = 0.47 ± 0.97 μM) exerted a 141-fold higher inhibitory potency than kojic acid. Kinetic studies’ results confirmed that compounds 2b and 2f are competitive tyrosinase inhibitors, which was supported by high binding affinities with the active site of tyrosinase by docking simulation. Docking results using a human tyrosinase homology model indicated that 2b and 2f might potently inhibit human tyrosinase. In vitro assays of 2b and 2f were conducted using B16F10 melanoma cells. Compounds 2b and 2f significantly and concentration-dependently inhibited intracellular melanin contents, and the anti-melanogenic effects of 2b at 10 μM and 2f at 25 μM were considerably greater than the inhibitory effect of kojic acid at 25 μM. Compounds 2b and 2f similarly inhibited cellular tyrosinase activity and melanin contents, indicating that the anti-melanogenic effects of both were due to tyrosinase inhibition. A strong binding affinity with the active site of tyrosinase and potent inhibitions of mushroom tyrosinase, cellular tyrosinase activity, and melanin generation in B16F10 cells indicates the PUSTC scaffold offers an attractive platform for the development of novel tyrosinase inhibitors.

Synthesis and Biological Evaluation of Novel Methyl 2-Hydroxy-5-Substituted Benzoate Derivatives as Mushroom Tyrosinase Inhibitors

Synthesis and biological evaluation of novel 4-hydroxybenzaldehyde derivatives as tyrosinase inhibitors.

Design, synthesis and evaluation of cinnamic acid ester derivatives as mushroom tyrosinase inhibitors.

Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase

Synthesis and Biological Evaluation of Polyhydroxy Benzophenone As Mushroom Tyrosinase Inhibitors

Methoxy-Substituted Tyramine Derivatives Synthesis, Computational Studies and Tyrosinase Inhibitory Kinetics

Synthesis and Inhibition of Tyrosinase Acitivity of New Gentisic Acid Derivatives

Design, Synthesis, Structural Insights, Tyrosinase Inhibition, and Sun Protection Factor of New Thiosemicarbazone Derivatives

Synthesis, Characterization and Biological Evaluation of Paeonol Thiosemicarbazone Analogues As Mushroom Tyrosinase Inhibitors.

Design and Synthesis of Biphenyl Derivatives As Mushroom Tyrosinase Inhibitors

Benzyl benzoates: New phlorizin analogs as mushroom tyrosinase inhibitors.

Design and Synthesis of Thiourea Derivatives with Sulfur-Containing Heterocyclic Scaffolds As Potential Tyrosinase Inhibitors

Synthesis and evaluation of 5-benzylidene(thio)barbiturate-β-d-glycosides as mushroom tyrosinase inhibitors

Discovery of Indole-Thiourea Derivatives as Tyrosinase Inhibitors: Synthesis, Biological Evaluation, Kinetic Studies, and In Silico Analysis

Investigation of the Efficacy of Benzylidene-3-methyl-2-thioxothiazolidin-4-one Analogs with Antioxidant Activities on the Inhibition of Mushroom and Mammal Tyrosinases

Refinement of Arylthiosemicarbazone Pharmacophore in Inhibition of Mushroom Tyrosinase

Alpha-substituted Derivatives of Cinnamaldehyde As Tyrosinase Inhibitors: Inhibitory Mechanism and Molecular Analysis.

Novel Anti-Melanogenic Compounds, (Z)-5-(Substituted Benzylidene)-4-thioxothiazolidin-2-one Derivatives: In Vitro and In Silico Insights

Inhibitory Effects of 5-Benzylidene Barbiturate Derivatives on Mushroom Tyrosinase and Their Antibacterial Activities.

Novel coumarin derivatives as potential tyrosinase inhibitors: Synthesis, binding analysis and biological evaluation

Design and Synthesis of 3,5-Diaryl-4,5-dihydro-1h-pyrazoles As New Tyrosinase Inhibitors.